[Primary hyperoxaluria]

Area of Science:

• Biochemistry
• Genetics
• Nephrology

Background:

• Primary hyperoxaluria (PHO) is a rare, inherited disorder of glyoxylate metabolism.
• It results from a deficiency in the liver enzyme alanine glyoxylate transaminase.
• PHO leads to the accumulation of oxalate, causing severe kidney damage.

Observation:

• Key symptoms include recurrent kidney stones, nephrocalcinosis, and progressive renal failure.
• Advanced PHO can lead to systemic oxalosis, affecting bones, vasculature, and the heart.
• Current treatments like dialysis and single organ transplantation offer poor outcomes.

Findings:

• Combined liver and renal transplantation effectively corrects the metabolic defect in PHO.
• This combined approach normalizes oxalate excretion and improves patient prognosis.
• Transplantation before severe renal decline (creatinine clearance < 10-20 ml/min) is crucial.

Implications:

• Combined liver-kidney transplantation represents the optimal therapeutic strategy for end-stage renal disease due to PHO.
• Early transplantation is recommended to prevent systemic oxalate deposition and complications.
• This intervention offers a chance for improved survival and quality of life for PHO patients.